Seoul, South Korea

Se-Pill Park

This inventor holds 1 USPTO granted patent. Top assignee: Maria Biotech Co., Ltd.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Se-Pill Park. Retrieved from https://idiyas.com/inventor/se-pill-park-4eyt70yi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Se-Pill Park: Pioneering Inventor from Seoul

Introduction: Se-Pill Park is a renowned inventor hailing from Seoul, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Se-Pill Park holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: Throughout his illustrious career, Se-Pill Park has worked with leading research institutions and tech companies, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Se-Pill Park has collaborated with top scientists, engineers, and inventors globally, fostering a culture of innovation and knowledge-sharing that has led to the development of impactful technologies with far-reaching implications.

Conclusion: Se-Pill Park's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, inspiring the next generation of innovators to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…